|
⚲
|
| Keyboard |
| NVP Associates LLC
✚
|
|
|---|---|
| CIK # | 0001545692 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| MBX Biosciences Inc | 63.8 | ||
| Billiontoone Inc | 40.5 | ||
| Zenas Biopharma Inc | 35.9 | ||
| Omada Health Inc | 31.8 | ||
| Virgin Group Acquisition Corp II | 4.1 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001545692] | |
| 3 | [0001545692] | |
| 4 | [0001545692] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Grove Collaborative Holdings Inc GROV
Class B Common Stock · derivative
|
2023-04-13 | Other | 135,480 | $0.00 | |
|
Grove Collaborative Holdings Inc GROV
Class A Common Stock
|
2022-11-23 | Conversion | 14,217,512 | $0.00 | |
|
Grove Collaborative Holdings Inc GROV
Class B Common Stock · derivative
|
2022-11-23 | Conversion | 14,217,512 | $0.00 | |
|
Udemy Inc UDMY
Common Stock
|
2021-11-02 | Conversion | 11,552,940 | ||
|
Udemy Inc UDMY
Series C Convertible Preferred Stock · derivative
|
2021-11-02 | Conversion | 10,134,082 | ||
|
Udemy Inc UDMY
Series D Convertible Preferred Stock · derivative
|
2021-11-02 | Conversion | 1,418,858 |